Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke [7]

Stroke

Volumn 38, Issue 2, 2007, Pages 255-

  Parkkinen, Jaakko ^a   Ojala, Pauli ^b   Niiranen, Jenni ^c   Jolkkonen, Jukka ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LYSOPHOSPHATIDYLCHOLINE; OROSOMUCOID; TRIPHENYLTETRAZOLIUM;

BRAIN BLOOD VESSEL; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHEMOTAXIS; CYTOSOL; LETTER; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER; STROKE; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; INFUSIONS, INTRAVENOUS; NEUROPROTECTIVE AGENTS; PROTEIN BINDING; RATS; SERUM ALBUMIN;

EID: 33846590563     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254506.06583.2d     Document Type: Letter

References (8)

1. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-I: physiological responses and safety results. Stroke. 2006;37:2100-2106.
2. Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-II: neurologic outcome and efficacy analysis. Stroke. 2006;37:2107-2114.
3. Muchitsch EM, Schwarz HP. Beneficial effect of albumin therapy attributable to α1-acid glycoprotein?; Ginsberg MD, Belayev L, Busto R. Response. Stroke. 2003;34:4-5.
4. Zalewski A, Macphee CH. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vas Biol. 2005;25:923-931.
5. Adibhatla RM, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Rad Biol Med. 2006;40:376-387.
6. Xie H, Bevan JA. Oxidized low-density lipoprotein enhances myogenic tone in the rabbit posterior cerebral artery through the release of endothelin-1. Stroke. 1999;30:2423-2430.
7. Ojala PJ, Hermansson M, Tolvanen M, Polvinen K, Hirvonen T, Impola U, Jauhiainen M, Somerharju P, Parkkinen J. Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein. Biochemistry. 2006;45:14021-14031.
8. Kinouchi H, Imaizumi S, Yoshimoto T, Yamamoto H, Motomiya M. Changes of polyphosphoinositides, lysophospholipid, and free fatty acids in transient cerebral ischemia of rat brain. Mol Chem Neuropathol. 1990;12:215-228.